CRP and breast carcinoma: Moreover, inflammatory serum biomarkers, such as C-reactive protein (CRP) and serum ferritin, are elevated in breast cancer patients and correlate with advanced tumor stage and poor clinical outcome [6], [7], [8], [9], [10].